Journal of Clinical and Translational Hepatology

Aims & Scope

Journal of Clinical and Translational Hepatology (JCTH) publishes high quality, peer-reviewed studies in the translational and clinical human health sciences of liver diseases.

JCTH has established high standards for publication of original research characterized by a study’s novelty, quality, and ethical conduct in the scientific process, as well as in the communication of the research findings.

Each issue includes review articles by leading authorities on topics in hepatology that are germane to the most current challenges in the field.

Special features include reports on the latest advances in drug development and technology that are relevant to liver diseases.

Regular features of JCTH also include editorials, correspondence, and invited commentaries on rapidly progressing areas in hepatology.

All articles published by JCTH, both solicited and unsolicited, must pass a rigorous peer review.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	4.2
2024	3.10

SJR (SCImago Journal Rank)

Year	Value
2024	1.095

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	54

Journal Rank

Year	Value
2024	4164

Journal Citation Indicator

Year	Value
2024	1665

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies

  Citation: 297

  Authors: Gong, Kenneth I., Qin-Qin, Rafael S., Giovanni, Christopher D., Sven Van, Wen-Yue, Ming-Hua

• Current and Future Treatment of Hepatocellular Carcinoma: An Updated Comprehensive Review

  Citation: 216

  Authors: Saleh, Muhammad, Ariel A., Tawfik

• Characteristics and Mechanism of Liver Injury in 2019 Coronavirus Disease

  Citation: 206

  Authors: Jie, Jian-Gao

• Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update)

  Citation: 192

  Authors: Jinlin, Guiqiang, Fusheng, Jun, Hong, Hui, Jian, Lanjuan, Jie, Qinghua, Jingmin, Zhongping, Jidong, Hong, Jifang, Jie, Fengmin, Qing, Lai

• Chylous Ascites: A Review of Pathogenesis, Diagnosis and Treatment

  Citation: 182

  Authors: Richa, Haleh, Arun, Enrique, David, George Y.

• Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver

  Citation: 147

  Authors: Eda, Yusuf

• Nonalcoholic Fatty Liver Disease: Dyslipidemia, Risk for Cardiovascular Complications, and Treatment Strategy

  Citation: 137

  Authors:

• Animal Models for Fibrotic Liver Diseases: What We Have, What We Need, and What Is under Development

  Citation: 137

  Authors:

• Hepatitis C Virus and Hepatocellular Carcinoma: A Narrative Review

  Citation: 136

  Authors: Page, Zunirah, Sujan, Ashwani K.

• Acetaminophen-Induced Hepatotoxicity: a Comprehensive Update

  Citation: 135

  Authors:

---